Journal
NEUROPHARMACOLOGY
Volume 55, Issue 6, Pages 961-968Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2008.06.048
Keywords
5-HT2A; 5-Hydroxytryptamine; Serotonin; PSD95; Arrestin; Caveolin; Lipid raft; RSK2; PKC; GPCR; Gq; PDZ; Post-synaptic density; Desensitization; Trafficking; Endocytosis; Internalization; Scaffolding
Categories
Funding
- National Institutes of Health [PHS RO1MH61887, U19MH82441, T32HD040127]
- UNC-Neurodevelopmental Disorders Research Center
Ask authors/readers for more resources
5-HT2A serotonin receptors are essential molecular targets for the actions of LSD-like hallucinogens and atypical antipsychotic drugs. 5-HT2A serotonin receptors also mediate a variety of physiological processes in peripheral and central nervous systems including platelet aggregation, smooth muscle contraction, and the modulation of mood and perception. Scaffolding proteins have emerged as important regulators of 5-HT2A receptors and our recent studies suggest multiple scaffolds exist for 5-HT2A receptors including PSD95, arrestin, and caveolin. In addition, a novel interaction has emerged between p90 ribosomal S6 kinase and 5-HT2A receptors which attenuates receptor signaling. This article reviews our recent studies and emphasizes the role of scaffolding proteins and kinases in the regulation of 5-HT2A trafficking, targeting and signaling. (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available